MX2015002705A - Compuestos de piridinona para usarse en terapia fotodinamica. - Google Patents

Compuestos de piridinona para usarse en terapia fotodinamica.

Info

Publication number
MX2015002705A
MX2015002705A MX2015002705A MX2015002705A MX2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A MX 2015002705 A MX2015002705 A MX 2015002705A
Authority
MX
Mexico
Prior art keywords
photodynamic therapy
pyridinone compounds
pyridinone
compounds
alkyl group
Prior art date
Application number
MX2015002705A
Other languages
English (en)
Spanish (es)
Inventor
Alison Curnow
Mark Wood
Alexis Perry
Original Assignee
Univ Exeter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Exeter filed Critical Univ Exeter
Publication of MX2015002705A publication Critical patent/MX2015002705A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
MX2015002705A 2012-09-03 2013-09-02 Compuestos de piridinona para usarse en terapia fotodinamica. MX2015002705A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1215675.8A GB201215675D0 (en) 2012-09-03 2012-09-03 Compound
PCT/GB2013/052297 WO2014033477A1 (en) 2012-09-03 2013-09-02 Pyridinone compounds for use in photodynamic therapy

Publications (1)

Publication Number Publication Date
MX2015002705A true MX2015002705A (es) 2015-12-01

Family

ID=47075165

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015002705A MX2015002705A (es) 2012-09-03 2013-09-02 Compuestos de piridinona para usarse en terapia fotodinamica.

Country Status (15)

Country Link
US (1) US9346758B2 (enExample)
EP (1) EP2892881B1 (enExample)
JP (1) JP2015526499A (enExample)
KR (1) KR20150068374A (enExample)
CN (1) CN104718190B (enExample)
AU (1) AU2013308197B2 (enExample)
BR (1) BR112015004732A2 (enExample)
CA (1) CA2883754A1 (enExample)
GB (1) GB201215675D0 (enExample)
IN (1) IN2015DN02514A (enExample)
MX (1) MX2015002705A (enExample)
RU (1) RU2015111137A (enExample)
SG (1) SG11201501604TA (enExample)
WO (1) WO2014033477A1 (enExample)
ZA (1) ZA201502153B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201215675D0 (en) 2012-09-03 2012-10-17 Univ Exeter Compound
EP3148528A1 (en) 2014-06-02 2017-04-05 University of Exeter Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy
CN112062713B (zh) * 2020-08-04 2023-03-31 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
GB201215675D0 (en) 2012-09-03 2012-10-17 Univ Exeter Compound

Also Published As

Publication number Publication date
ZA201502153B (en) 2017-07-26
IN2015DN02514A (enExample) 2015-09-11
AU2013308197B2 (en) 2018-02-01
EP2892881B1 (en) 2017-07-19
CN104718190B (zh) 2017-03-08
BR112015004732A2 (pt) 2018-04-17
RU2015111137A (ru) 2016-10-20
AU2013308197A1 (en) 2015-04-09
GB201215675D0 (en) 2012-10-17
EP2892881A1 (en) 2015-07-15
CA2883754A1 (en) 2014-03-06
JP2015526499A (ja) 2015-09-10
KR20150068374A (ko) 2015-06-19
US9346758B2 (en) 2016-05-24
US20150210642A1 (en) 2015-07-30
CN104718190A (zh) 2015-06-17
WO2014033477A1 (en) 2014-03-06
SG11201501604TA (en) 2015-05-28

Similar Documents

Publication Publication Date Title
MY164776A (en) Heterocyclic compound
IN2014DN07509A (enExample)
MX377552B (es) Proceso para preparar un compuesto antiviral de formula i.
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
NZ705705A (en) Ret inhibitor
PH12015501316A1 (en) Heterocyclic compound
IN2014MN02598A (enExample)
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
TN2014000415A1 (en) Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
GEP20156372B (en) Pyridazinone compounds and their use as daao inhibitors
MY170262A (en) Dicarboxylic acid compound
MX2016007861A (es) Compuestos de ácido dimetilbenzoico.
MX351863B (es) Compuesto de anillo fusionado quinolilpirrolopirimidilo o sal del mismo.
IN2014CN04449A (enExample)
JO3318B1 (ar) مثبطات bace
JO3196B1 (ar) عملية تحضير ملح ل – ارجينين البيريندوبريل
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
MX2016004967A (es) Tratamiento para cancer pancreatico.
IN2014DN06192A (enExample)
MX369470B (es) Medios y método para el tratamiento de tumores sólidos.
MX2014009084A (es) Derivados de pirimidooxazocina como inhibidores de mtor.
MX359399B (es) Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
IN2015DN02514A (enExample)
IN2014CN04922A (enExample)
MX358151B (es) Derivado de sitaxentan.